<p>All animals were sensitised i.p. with OVA/Al (OH)<sub>3</sub> and subsequently challenged i.n. with PBS or OVA (3 days) and PBS, LPS or Poly (I:C) (4 days). 24 hrs after the final challenge, changes in lung resistance (R<sub>L</sub>) in response to increasing doses of methacholine (MCh) was measured using the flexiVent animal respirator. Data is represented as mean resistance (R<sub>L</sub>) ± SEM. (A) Animals were treated with PBS or LPS for 4 days following OVA or PBS treatment. (B) Animals were treated with PBS or Poly (I:C) for 4 days following OVA or PBS treatment. ¤ p<0.05 comparing EC<sub>50</sub> values between OVA-PBS and OVA-LPS or OVA-PBS and OVA-Poly (I:C) using one-way ANOVA followed by a Tukey multiple-comparison post-test....
<p>Twenty-four hours after the last inhalation of OVA or PBS, mice sensitized EC with OVA were monit...
<p>The OVA-sensitized and challenged group: mice were sensitized on days 1, 3, 5, 7, 9, 11 and 13 by...
<p>(A) AHR to methacholine. AHR was assessed in OVA-sensitized <i>PLCε</i><sup>+/+</sup> (<i>filled ...
<p>(A) Changes in lung resistance (R<sub>L</sub>) and (B) compliance (C<sub>L</sub>) in response to ...
<p>(a) Lung resistance in LPS-rich and LPS-free OVA challenged mice 48 hours following three OVA cha...
<p>To determine bronchial hyperresponsiveness, lung function analysis was performed using the IPL an...
<p>Mice (n = 8) were sensitized with OVA/Alum and received a first series of 3 OVA inhalation challe...
<p>Mice (n = 8) were sensitized with OVA/Alum and received 3 OVA or PBS inhalation challenges. TLR-2...
<p>Mice (n = 8) were sensitized with OVA/Alum and received 4 OVA or PBS inhalation challenges. TLR-2...
<p>AHR was measured using plethysmography 24 h after the final OVA challenge, in mice given various ...
<p>Twenty-four hours after the final intranasal CKA or PBS administration, to evaluate the inhibitor...
<p>(A) Changes in lung resistance (R<sub>L</sub>) were recorded for 3 min after challenge with aeros...
<p>Changes in lung resistance were recorded for 3 min after challenge with aerosolized MCH for 20 se...
<p>Airway hyperreactivity was directly measured by changes in airway resistance and lung compliance ...
<p>WT or JH<sup>-/-</sup> mice were intranasally exposed to OAAH or PBS for 2 weeks, as described in...
<p>Twenty-four hours after the last inhalation of OVA or PBS, mice sensitized EC with OVA were monit...
<p>The OVA-sensitized and challenged group: mice were sensitized on days 1, 3, 5, 7, 9, 11 and 13 by...
<p>(A) AHR to methacholine. AHR was assessed in OVA-sensitized <i>PLCε</i><sup>+/+</sup> (<i>filled ...
<p>(A) Changes in lung resistance (R<sub>L</sub>) and (B) compliance (C<sub>L</sub>) in response to ...
<p>(a) Lung resistance in LPS-rich and LPS-free OVA challenged mice 48 hours following three OVA cha...
<p>To determine bronchial hyperresponsiveness, lung function analysis was performed using the IPL an...
<p>Mice (n = 8) were sensitized with OVA/Alum and received a first series of 3 OVA inhalation challe...
<p>Mice (n = 8) were sensitized with OVA/Alum and received 3 OVA or PBS inhalation challenges. TLR-2...
<p>Mice (n = 8) were sensitized with OVA/Alum and received 4 OVA or PBS inhalation challenges. TLR-2...
<p>AHR was measured using plethysmography 24 h after the final OVA challenge, in mice given various ...
<p>Twenty-four hours after the final intranasal CKA or PBS administration, to evaluate the inhibitor...
<p>(A) Changes in lung resistance (R<sub>L</sub>) were recorded for 3 min after challenge with aeros...
<p>Changes in lung resistance were recorded for 3 min after challenge with aerosolized MCH for 20 se...
<p>Airway hyperreactivity was directly measured by changes in airway resistance and lung compliance ...
<p>WT or JH<sup>-/-</sup> mice were intranasally exposed to OAAH or PBS for 2 weeks, as described in...
<p>Twenty-four hours after the last inhalation of OVA or PBS, mice sensitized EC with OVA were monit...
<p>The OVA-sensitized and challenged group: mice were sensitized on days 1, 3, 5, 7, 9, 11 and 13 by...
<p>(A) AHR to methacholine. AHR was assessed in OVA-sensitized <i>PLCε</i><sup>+/+</sup> (<i>filled ...